Tuesday, December 4, 2012

FDA announce Two-Week Grace Period for Generic Drug Facility Identification


FDA  announced a two-week grace period, until December 18, 2012, for Generic Drug Facilities that have not yet successfully completed the self-identification process.
The FY 2013 reporting period for facility self-identification closed on December 3, 2012.  Under the statute, generic drug products manufactured in facilities that have not self-identified, or including active ingredients manufactured in facilities that have not self-identified, are misbranded. 
source: fda

Tuesday, October 9, 2012

US FDA against illegal online pharmacies

The U.S. FDA  took action  against more than 4,100 Internet pharmacies that illegally sell potentially dangerous, unapproved drugs to consumers. Actions taken include civil and criminal charges, seizure of illegal products, and removal of offending websites.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm322492.htm

Tuesday, August 21, 2012

New FDA Medical Device Establishment Registration Requirements

FDA published the new requirements for Medical Device Establishments. As per the new requirements All medical device establishments - both domestic and foreign -  needs to pay FDA registration fee regardless of  activities conducted in the facility. the new fee for the year 2013 which starts from October 1st will be USD 2575.

Tuesday, March 13, 2012

Sunday, February 26, 2012

Toothbrush Can Chip Teeth and Cause Choking


When using your electric toothbrush, you don’t expect parts of the device to pop off and chip your tooth, fly into your eyes or get stuck in your throat.
But that’s exactly what has happened to some users of the battery-powered Arm & Hammer Spinbrush—or the Crest Spinbrush, as it was called before 2009.

Sunday, February 12, 2012

FDA Detention- Food, Medical Device, Cosmetics and Drugs

Most of the products detained by FDA are due to non-compliance with FDA requirements. Liberty Management Group Ltd. assists exporters and importers to release the detained product by brought the product in to compliance with the FDA regulations